Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine Augmentation with Ziprasidone or Risperidone
NCT00224315Phase 4Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ziprasidone, risperidone in schizophrenia, schizoaffective disorder, sponsored by Central Institute of Mental Health. Started Nov 2003; status: completed.
02
Drugs
ziprasidonerisperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00224315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224315.